Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 4:04 PM

Hepatitis B

Type: Keyphrase
Name: Hepatitis B
First Reported 11/19/2009 - Updated 11/19/2009 - 2 Documents (in Biology)
Hepatitis B targets men more viciously
The Hepatitis B virus (HBV) targets men more readily than women, triggering serious complications like cirrhosis and liver cancer, says a new study.Men infected with HBV are also six times more likely than women to develop a chronic form of the disea ... [Times of India - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Medicine)
Dynavax Technologies Corporation (DVAX) Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B Therapy
- (NASDAQ: DVAX) announced today that enrollment has been completed for the first of three cohorts of patients receiving DV-601 hepatitis B therapy in a Phase 1b clinical trial. The safety profile of patients in the first cohort met pre-specified criteria ... [BioSpace - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Needle exchange programme in prisons urged
Operators of the national needle exchange programme are calling for it to be expanded into the country's prisons.About 200 needle exchange clinics operate around the country, distributing 3 million clean needles this year alone. The programme has been ... [Radio New Zealand - 11/19/2009]
First Reported 2 hours ago - Updated 2 hours ago - 1 Documents (in Biology)
AIIMS advocates special test to make blood transfusion safer
New Delhi, Nov 21 : About 20,000 patients in India could be at risk of getting infected blood -- unknown to them and even the donors. Doctors at the premier All India Institute of Medical Sciences (AIIMS) here Saturday advocated a special test to detect ... [Topnews.in - 2 hours ago]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Health)
New treatment for hemophilia launched in India
A new genetically engineered treatment for hemophilia, a dreaded disease where blood doesn't clot, was launched here Wednesday by a private pharmaceutical company.Unlike other procedures, this treatment won't require donor blood for transfusion.The treatment ... [Webindia123 - 11/19/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Health)
I was shattered: teen's dental HIV scare
Patients say they are shocked and shattered after being treated at the Bundaberg Dental Clinic in north Queensland on November 6 - the day instruments were not sterilised.A 16-year-old girl is one of hundreds of patients being tested for HIV and Hepa ... [ABC Online - 11/17/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Health)
Entecavir (Baraclude) and Tenofovir (Viread) Rescue Therapy for Chronic Hepatitis B Patients with Advanced Fibrosis and Prior Treatment Failure
In this open-label cohort study, investigators from 8 referral centers in Europe assessed the efficacy and safety of tenofovir plus entecavir in treatment-experienced hepatitis B patients with advanced liver disease. Past treatment with single nucleoside/nucleotide ... [HIV and Hepatitis.com - 11/18/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Health)
Pegylated Interferon plus Ribavirin Can Effectively Treat both Hepatitis B and C In Dually Infected Patients
Due to overlapping routes of transmission, many people are coinfected with both hepatitis B and C, a combination that increases the risk of liver disease progression. Researchers from Taiwan previously found that HBV/HCV coinfected patients had a relatively ... [HIV and Hepatitis.com - 11/18/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents
National policy on Hepatitis B to be launched next year
Health parliamentary secretary Joe Cassar yesterday launched a consultation document aimed to lead to a national policy on Hepatitis B, to be implemented sometime towards the middle of next year.“Around one per cent of the Maltese population suffered ... [Malta Independent Daily - 11/18/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Health)
Agonizing Wait For Dental Patients Treated With Unsterilised Equipment
It is going to be an agonizing wait for the dental patients who recently visited a clinic in Bundaberg, Queensland for they have been treated with unsterilized equipment, potentially exposing them to blood-borne diseases including HIV.One batch of equipment ... [MedIndia - 11/18/2009]
First Reported 11/02/2009 - Updated 11/03/2009 - 6 Documents (in Health)
No hepatitis B link to pancreatic cancer
CommentBOSTON, Nov. 3 (UPI) -- Hepatitis B does not increase the risk of pancreatic cancer but age does, U.S. researchers say.Researchers at Henry Ford Hospital in Detroit say their study of more than 74,000 patients contradicts a previous study suggesting ... [UPI - 11/03/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 2 Documents
9th November, 2009 SYLiF screens 1000 people on Hepatitis 'B' in Accra
Mr Isaac Agyemang, Herbalist In-Charge of Lord Health Care,'We educate the people to do the test and if you are found negative, we counsel you, but if you are found positive, we give you supplements,' he said.He said plans were very far advanced to extend ... [Ghana News Agency - 11/10/2009]

Quotes

"They said to me that there was a risk I could have HIV, Hepatitis B and C" she said
Agonizing Wait For Dental Patients Treated With Unsterilised Equipment [MedIndia - 11/18/2009]
...' However, they added, "More data are certainly needed to judge about the long-term safety, efficacy and prevention of emergence of new viral mutations in this difficult to treat patient population." Asklepiosklinik St...
Entecavir (Baraclude) and Tenofovir (Viread) Rescue Therapy for Chronic Hepatitis B Patients with ... [HIV and Hepatitis.com - 11/18/2009]
...2012 mit einem weiteren Preisrckgang auf 2,83 US-Dollar je Dosis zu rechnen sei, eine Senkung von 22 Prozent ber einen Zeitraum von acht Jahren. "Dieser Preisrckgang ist kein Zufall, sondern das Resultat einer Strategie zur optimalen Nutzung der Kaufkraft mehrerer hundert Millionen Menschen, so der stellvertretende UNICEF-Direktor Saad Houry. "Offensichtlich erkennt die Industrie den Markt und reagiert, gleichgltig ob sich dieser Markt in armen oder reichen Lndern befindet. Das Modell der Allianz fngt an zu greifen und wir sind zuversichtlich, dass sich der Trend fortsetzen wird, wenn der Wettbewerb und die Nachfrage im Laufe der Zeit zunehmen. Das Geschftsmodell der GAVI beruht auf der Erwartung, dass die steigende Nachfrage nach Impfstoffen in Entwicklungslndern mehr Unternehmen zu deren Herstellung veranlasst und dass der sich daraus ergebende Wettbewerb die Preise nach unten drckt. Die neuen Daten belegen den Erfolg. Whrend im Jahr 2001 nur ein Unternehmen den Fnffachimpfstoff produzierte, gibt es heute vier Hersteller. Zwei davon sind indische Unternehmen, deren Produkte im Jahr 2008 auf den Markt kamen. Derzeit stammen die Hlfte der von der GAVI finanzierten Impfstoffe von Herstellern aus Entwicklungslndern. Gesundheitsexperten sind der Ansicht, dass sich der Effekt der niedrigeren Preise fr den Fnffachimpfstoff bis ber den Kern der Empfngerlnder von GAVIs Hilfsleistungen erstrecken knnte, welche die 72 rmsten Lnder der Welt sind. Zum Beispiel gilt die Einfhrung des Fnffachimpfstoffs in vielen mittleren Einkommenslndern nun als wahrscheinlicher, da dessen Preis fr die rmsten Lnder unter die Marke von 3 US-Dollar gefallen ist. "Es gibt zwei Mglichkeiten, um die Anzahl der Kinder zu erhhen, die wir mit lebensrettenden Impfstoffen erreichen knnen, sagte Dr. Lob-Levyt. "Erstens knnen wir mehr Finanzmittel aufbringen. Zweitens knnen wir Druck erzeugen, um die Preise von Impfstoffen weiter zu senken. Angesichts des gegenwrtigen Wirtschaftsklimas und der schwierigen Finanzentscheidungen, die den Spendern bevorstehen, hoffe ich, dass die Impfstoffindustrie ihren Beitrag leisten wird, damit wir die Preise schneller senken knnen. ber 250 Millionen Kinder geimpft - vier Millionen Todesflle verhindert Die Allianz legte heute neue Daten vor, denen zufolge bis Ende 2009 ber vier Millionen frhzeitige Todesflle infolge von Keuchhusten, Haemophilus influenzae Typ B (Hib) und Hepatitis B dank der Untersttzung durch GAVI verhindert werden."
GAVIs Einfluss auf den Markt für Impfstoffe senkt die Preise [FinanzNachrichten.de - 11/18/2009]
...period of validity is interpreted by the national authorities and there seems to be different interpretations and practices at the national level. "It has been suggested to establish a formal working group with professionals in the field of ART and other relevant professionals such as microbiologists as well as national regulators" , explained Dr. Sren Ziebe. 'This group, if established by the Commission, could be very useful in order to reach a consensus in this area', he said
Statement of ESHRE on the European Commission proposal of viral screening [Genetic Engineering News - 11/16/2009]

More Content

All (273) | News (198) | Reports (25) | Blogs (11) | Audio/Video (0) | Fact Sheets (4)
sort by: Date | Relevance
AIIMS advocates special test to make blood tran... [Topnews.in - 2 hours ago]
Ranking CEO Wealth Creation [Chief Executive - 20 hours ago]
Bare-foot doctors bring gift of life in China's... [People's Daily Online - 11/20/2009]
Needle exchange programme in prisons urged [Radio New Zealand - 11/19/2009]
Donated blood may be unsafe even after test [Times of India - 11/19/2009]
Dynavax Technologies Corporation (DVAX) Complet... [BioSpace - 11/19/2009]
Dynavax Completes Enrollment of First Cohort of... [Market Wire via MSN Money - 11/19/2009]
Hepatitis B targets men more viciously [Times of India - 11/19/2009]
Hepatitis B targets men more viciously than women [Sify - 11/19/2009]
New treatment for hemophilia launched in India [Webindia123 - 11/19/2009]
'Bone-Crushing' Dengue Fever MUCH Greater Threa... [Mercola - 11/18/2009]
Why Hepatitis B Hits Men Harder Than Women [Infection Control Today - 11/18/2009]
Agonizing Wait For Dental Patients Treated With... [MedIndia - 11/18/2009]
National policy on Hepatitis B to be launched n... [Malta Independent Daily - 11/18/2009]
Pegylated Interferon plus Ribavirin Can Effecti... [HIV and Hepatitis.com - 11/18/2009]
Entecavir (Baraclude) and Tenofovir (Viread) Re... [HIV and Hepatitis.com - 11/18/2009]
GAVIs Einfluss auf den Markt für Impfstoff... [FinanzNachrichten.de - 11/18/2009]
I was shattered: teen's dental HIV scare [ABC Online - 11/17/2009]
Silicon Sweatshops: The China connection [GlobalPost - 11/17/2009]
Statement of ESHRE on the European Commission p... [Genetic Engineering News - 11/16/2009]
Stocks That Stand Out For Nov. 13th, 2009 Are E... [Pharmacy Choice - 11/14/2009]
Stocks That Stand Out For Nov. 12th, 2009 Are L... [Pharmacy Choice - 11/13/2009]
Stocks That Stand Out For Nov. 12th, 2009 Are L... [TMC Net - 11/13/2009]
Stocks That Stand Out For Nov. 12th, 2009 Are B... [Pharmacy Choice - 11/13/2009]
ICU Medical Inc. (ICUI) Chairman George A Lopez... [Guru Focus - 11/13/2009]
Hepatitis B does not increase risk for... [Irish Health.com - 11/12/2009]
Gilead Announces Long-Term Data from Two Pivota... [Pharmacy Choice - 11/12/2009]
Search for fugitive monkey in East Tampa called... [St. Petersburg Times - 11/12/2009]
Search for fugitive monkey in east Tampa called... [St. Petersburg Times - 11/12/2009]
Biostar Pharmaceuticals reports financial resul... [News-Medical.Net - 11/12/2009]
1 2 3 4 5 6 7
In Focus
  •  
Henry Ford, Jim Butler, Joe Cassar, [more]
  •  
BioStar, Celsion Corporation, Merck & Co Inc, [more]
  •  
American Association for the Study of ..., Food and Drug Administration, Centers for Disease Control and Preve ..., [more]
  •  
lamivudine, Hepatitis B Virus, Vaccine, [more]
  •  
Accra, Boston (Massachusetts, United States), Beijing, [more]
  •  
China, Taiwan, Australia, [more]
  •  
Medicine, Medication, Biology, [more]
  •  
Pharma & Biotech, Health, IT, [more]
NEJM — Collection Updates for Liver ..., NEJM — Collection Updates for Viral ..., HIV and Hepatitis.com, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Turning 'crazy' into learnin-- XMRV from contam... [ScienceBlogs : Combined Feed - 11/20/2009]
I hate how the 'new' Technorati doesnt let you see everyone whos linked to you. Sometimes, smaller blogs with less traffic write a neat post and link to me, but ...
Some monkey business in autism research, 2009 e... [Respectful Insolence - 10/07/2009]
As you may have noticed, I've fallen into a groove (or, depending on your point of view, a rut) writing about anti-vaccine lunacy. The reason is simple. While I ...
Some monkey business in autism research, 2009 e... [ScienceBlogs : Combined Feed - 10/07/2009]
As you may have noticed, I've fallen into a groove (or, depending on your point of view, a rut) writing about anti-vaccine lunacy. The reason is simple. While I ...
David Kirby: Kathleen Sebelius: Autism Now Hits... [The Huffington Post Full Blog Feed - 10/04/2009]
Washington loves to dump its bad news on a Friday afternoon, and today it confirmed that one percent of American children (and by extension, perhaps 1-in-58 ...
James Moore: Why We Worry about Vaccines [The Huffington Post Full Blog Feed - 10/01/2009]
Even as doctors try to reassure the public, and TV news anchors get their swine flu shots on the morning news, there remains a great unease about vaccinations ...
1 2 3

  •  
  •  
  •